Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: A non-randomized comparison using an explanatory analysis: A Gynecologic Oncology Group study
- 1 October 2005
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 99 (1) , 71-79
- https://doi.org/10.1016/j.ygyno.2005.05.012
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.Journal of Clinical Oncology, 1997
- A note on the calculation of expected survival, illustrated by the survival of liver transplant patientsStatistics in Medicine, 1991
- Second Thoughts about Second-Look Laparotomy in Advanced Ovarian CancerNew England Journal of Medicine, 1990
- FAILURE OF SECOND-LOOK LAPAROTOMY TO INFLUENCE SURVIVAL IN EPITHELIAL OVARIAN CANCERThe Lancet, 1988
- Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian CancerNew England Journal of Medicine, 1982
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958